Abstract
Hydrogen production involves the use of hydrogenase (H2ase) enzyme, especially for photohydrogen production. Specific detection of fermentative hydrogen producing bacteria from the microbial communities is achieved based on the universal Iron-hydA primers. In the present study, the primers for the H2ase gene were designed, followed by the isolation of the DNA from the selected hydrogen producing microorganisms. Amplification of the genome by the designed primers were carried out by the polymerase chain reaction. The PCR primers designed were HyF, Hyff, HyR and Hyrr. The primers were analyzed and best fitted by the computer aided program. The resulted primers were amplified (400 bps) from the genome of the selected hydrogen producing microorganisms. This work was carried out as a preliminary assay in molecular cloning of hydrogenase genes by primer designing from the selected strains for the improvement of hydrogen production process.
Keywords: Hydrogen production, hydrogenase gene, nitrogenase gene, DNA isolation, PCR primers, primer designing, HyF, Hyff, HyR and Hyrr, gene amplification, Hydrogen uptake, autotrophic, thermophilic, oxidizing bacterium, H-cluster
Current Biotechnology
Title:PCR Designing and Amplification of Partial Hydrogenase Gene from Selected Hydrogen Producing Microorganisms
Volume: 1 Issue: 3
Author(s): A. G. Murugesan, S. Yoga Chithra and K. Bala Amutha
Affiliation:
Keywords: Hydrogen production, hydrogenase gene, nitrogenase gene, DNA isolation, PCR primers, primer designing, HyF, Hyff, HyR and Hyrr, gene amplification, Hydrogen uptake, autotrophic, thermophilic, oxidizing bacterium, H-cluster
Abstract: Hydrogen production involves the use of hydrogenase (H2ase) enzyme, especially for photohydrogen production. Specific detection of fermentative hydrogen producing bacteria from the microbial communities is achieved based on the universal Iron-hydA primers. In the present study, the primers for the H2ase gene were designed, followed by the isolation of the DNA from the selected hydrogen producing microorganisms. Amplification of the genome by the designed primers were carried out by the polymerase chain reaction. The PCR primers designed were HyF, Hyff, HyR and Hyrr. The primers were analyzed and best fitted by the computer aided program. The resulted primers were amplified (400 bps) from the genome of the selected hydrogen producing microorganisms. This work was carried out as a preliminary assay in molecular cloning of hydrogenase genes by primer designing from the selected strains for the improvement of hydrogen production process.
Export Options
About this article
Cite this article as:
G. Murugesan A., Yoga Chithra S. and Bala Amutha K., PCR Designing and Amplification of Partial Hydrogenase Gene from Selected Hydrogen Producing Microorganisms, Current Biotechnology 2012; 1 (3) . https://dx.doi.org/10.2174/2211550111201030212
DOI https://dx.doi.org/10.2174/2211550111201030212 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bisthiourea Derivatives of Dipeptide Conjugated Benzo[d]isoxazole as a New Class of Therapeutics: Synthesis and Molecular Docking Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Predicting Subcellular Localization of Mycobacterial Proteins by Using Chous Pseudo Amino Acid Composition
Protein & Peptide Letters Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases
Coronaviruses Mucosal Delivery of Vaccines: Role of Mucoadhesive/Biodegradable Polymers
Recent Patents on Drug Delivery & Formulation iMethylK-PseAAC: Improving Accuracy of Lysine Methylation Sites Identification by Incorporating Statistical Moments and Position Relative Features into General PseAAC via Chou’s 5-steps Rule
Current Genomics Editorial (Thematic Issue: Recent Advances in the Structure-Based Drug Design and Discovery)
Current Topics in Medicinal Chemistry Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem
Infectious Disorders - Drug Targets Isoniazid: Metabolic Aspects and Toxicological Correlates
Current Drug Metabolism Saccharomyces cerevisiae β-Carbonic Anhydrase: Inhibition and Activation Studies
Current Pharmaceutical Design Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Human Peroxiredoxins 1 and 2 and Their Interacting Protein Partners; Through Structure Toward Functions of Biological Complexes
Protein & Peptide Letters Ligustrazine Derivatives. Part 8: Design, Synthesis, and Preliminary Biological Evaluation of Novel Ligustrazinyl Amides as Cardiovascular Agents
Medicinal Chemistry Targeting Cytokines: Production and Characterization of Anti-TNF-α scFvs by Phage Display Technology
Current Pharmaceutical Design Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity
Current Respiratory Medicine Reviews Antimicrobial Activity of Diazenyl Derivatives: An Update
Current Topics in Medicinal Chemistry The Application of Optical Technology in Microfluidic Systems
Current Proteomics Structure-Based Virtual Ligand Screening: Recent Success Stories
Combinatorial Chemistry & High Throughput Screening Targeting Bacterial RNA Polymerase: Promises for Future Antisense Antibiotics Development
Infectious Disorders - Drug Targets Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria
Current HIV Research Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research